PPT-Subgroup Efficacy Analyses of
LongActing Subcutaneous Lenacapavir in Heavily TreatmentExperienced People With HIV in the Phase 23 CAPELLA Study 1 ICH Study Center Hamburg Germany 2 Orlando Immunology
Download Presentation
"Subgroup Efficacy Analyses of" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.